30 presentations showcase breadth of data from Janssen’s Immunodermatology pipeline across five commercialized and investigational therapies SPRING HOUSE, Pa., Oct. 9, 2023 /PRNewswire/ — Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, today announced that 30…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.